Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

The requested reference [dad7e44da6af212dea959801e6b64b5cc6980c2f] no longer exists in our database. It has been replaced by the current reference: [4262e9377fe36e531703a7bc975649e1c1359b9b]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult polymyositis (PM) and dermatomyositis (DM).
Epistemonikos ID: da6585fa8ff90d7940b64a0484edfb61194b9a8f
First added on: May 11, 2024